Navigation Links
Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
Date:12/3/2008

NEW YORK, Dec. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the company will provide an update on milestones achieved in 2008 and preview objectives for 2009 during its annual Investor and Analyst Briefing to be held in New York City today.

David Smoller, Ph.D., President of Sigma-Aldrich Corporation's Research Biotech Business Unit will discuss the progress and expected potential of the two companies' collaboration to commercialize zinc finger DNA-binding protein (ZFP) technology for research applications. Dr. Smoller will be joined by Edward Lanphier, Sangamo's president and CEO and other members of Sangamo's senior management team.

"Sigma is committed to providing breakthrough products to its customers in laboratories worldwide and we expect Sangamo's ZFP technology to be nothing short of revolutionary for research applications," commented Dr. Smoller. "Marketed under the trademark CompoZr, the zinc finger nuclease (ZFN) technology makes available, for the first time, simple, efficient genomic editing. CompoZr(TM) ZFN reagents can be used to efficiently create modified cell lines and model organisms with precise and heritable gene deletions, insertions or modifications using simple, widely used laboratory procedures. This is proven technology with strong potential."

"The past year has been a year of real progress for our ZFP technology platform," said Edward Lanphier, president and CEO of Sangamo. "We are successfully translating the broad applicability of our technology into opportunities for both novel human therapeutics and non-therapeutic industrial applications. Our unique hybrid business model maximizes the value of our ZFP technology platform and has enabled us to make significant progress in moving our lead ZFP Therapeutic into multiple Phase 2 clinical trials
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
2. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
3. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
4. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
7. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
8. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
11. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...19 Ligon Discovery, Inc., which us...y to find drugs against high-value targets, today ... led by incTANK Ventures. The company will use the...n that will screen over 100 high-value disease pro...es General Partner Christian Bailey joins the boar...
(Date:11/19/2009)...19 Mach 7 Technologies, a global...ge management solutions, and QStar Technologies ha... neutral archive solution through their common US ...ational leader in providing digital image distribu...ry. Under the agreement, Data Distributing will b...
(Date:11/19/2009)...l Internet Week of Action ,, SILVER SPRING, Md... and Drug Administration today completed a coordin...nternational Internet Week of Action (IIWA), inten...ucts. ,, (Logo: http://www.newscom.com/cgi-bi..., the FDA,s Office of Criminal Investigations (OCI...
Breaking Medicine Technology:Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4FDA Issues 22 Warning Letters to Web Site Operators 2Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology 47724 1Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology 47724 2China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 1China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 2China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 3Pelosi Remarks Before Meeting with Secretary of Health and Human Services Kathleen Sebelius 47718 1Pelosi Remarks Before Meeting with Secretary of Health and Human Services Kathleen Sebelius 47718 2
...11 Pharmacyclics,Inc. (Nasdaq: PCYC ) today anno...ny,s novel highly-selective histone deacetylase (H...ne deacetylase 8 (HDAC8)-specific inhibitor,PCI-34...s in the February 7,issue of Leukemia., Histone d...ant in,managing a multitude of cellular functions....
...ety Profile and Long Lasting Immunity, MCLEAN, Va...y, a US/Hungarian clinical-stage biopharmaceutical...ed immunotherapeutic platform technology,announced...rmaVir Patch, a,topically administered HIV immune ... Patch Treatment of HIV+ Individuals Induces Long ...
Other Medicine Technology:Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor 2Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor 3Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections 2Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections 3
(Date:11/20/2009)... , ST. LOUIS, Nov. 20 /PRNewswire-FirstCall/ -...nced that it will present at the Bank of America M...cember 2-3, 2009, at the Crowne Plaza Hotel Times ...t Wednesday, December 2nd at 8:30 a.m. Eastern Tim...ss a live, audio webcast of Centene,s presentation...
(Date:11/20/2009)..., WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNew... on a mission to redefine what it means to be "hap...l counselor with a specialty in family counseling ...Forest University, Gladding says research shows th... to sadness and even depression during the holiday...
(Date:11/20/2009)... , NEW YORK, Nov. 20 /PRNewswire-FirstCall/ ...ced that it will broadcast Doctor Radio Reports..., an in-depth special hosted by veteran journalist...m/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Docto...About Mammograms will air November 21 live at 1...
(Date:11/20/2009)...durations of exposure to formaldehyde used for emb...h an increased risk of death from myeloid leukemia...er 20 in the Journal of the National Cancer Insti...ality from lymphohematopoietic malignancies and br...l industry workers, all of whom may have worked wi...
(Date:11/20/2009)...tle, Washington) November 20, 2009Emergency medica...ess an estimated 350,000 cardiac arrests each year...cardiac arrest survive. Better quality cardiopulm...EMS providers may be associated with better patien...(ROC) is the largest clinical research network to ...
Breaking Medicine News(10 mins):Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...gnant women who are working , , FRIDAY, Ma...d it,s even harder when you,re working while pregn...hese challenges, working mothers-to-be can enjoy t... Medical Center and an expecting mother, said in a...
... 2 Today, one in five Americans,suffers from the ... and,Prevention (CDC) projects that by the year 20...rthritis, up from current estimates of 46 million...., is crucial in preventing and,managing the nation...
... 2 In an effort to help companies more,easily com...OSHA, EPA as,well as other federal and state regul...ine.com ), a leader in on-demand Material Safety D...fering., With MSDSonline,s training solutions, co...
...early use of antibiotics reversed damage caused by...News) -- Prompt treatment of a common stomach infe... cancer, according to tests on mice done by resear...ent of Helicobacter pylori can reduce or elimina...
...ien to be Master Of Ceremonies, Honorees Recogniz... Fifth Annual Awards Gala, May 7, 2008, WASHINGTO...le will be the featured entertainer when the Lupus...h.D., President of Research and Development, Execu...
...May 2 Today, 1.1 billion people,lack access to sa...ation,even though many existing technologies and a...anitation, and hygiene education. In a report rele...The,good news is there already are many workable s...
Other Medicine News:Health News:Pregnancy and Work Can Work 2Health News:Pregnancy and Work Can Work 3Health News:GET UP AND MOVE! May is Arthritis Awareness Month - The Perfect Time to Learn the Importance of Staying Active 2Health News:MSDSonline Expands On-Demand Training Offering 2Health News:Treating Stomach Infection Early Protects Against Cancer 2Health News:Grammy Award Winner Patti LaBelle Is Featured Entertainer at Lupus Foundation of America Awards Gala 2Health News:Improving Access to Safe Water, Sanitation, Hygiene Requires Better Decision-Making Tools, Finds Joint Wilson Center-Pacific Institute Report 2
AOA Near PT Acuity Card - BCAOA
...many common print sizes, from newspaper headline t...ides the examiner a starting point to determine ac...ellow styrene for increased contrast. It features ...ns include Jaeger, M notation, lower case point si...
Spanish Near Point Card
... pages of various contrast levels showing 5 Lea Nu...t levels are 25%, 10%, 5%, 2.5% and 1.25%. These f...ces. These two sets are used for the same test. Ea...inst memorization. Includes instructions. Measures...
Medicine Products: